<DOC>
	<DOCNO>NCT01024257</DOCNO>
	<brief_summary>PURPOSE : To affirm effectiveness complication rate postoperative single-dose beta-irradiation ( RT ) ( 90 ) Sr case primary pterygium clinical trial . METHODS AND MATERIALS : This trial design prospective , randomize , single center study . Surgery perform case accord conjunctival autograft technique . One thousand four patient 108 pterygium postoperatively randomize either beta-RT observation . In case beta-RT , ( 90 ) Sr eye applicator use deliver 1000 cGy sclera surface dose rate 200 250 cGy/min . After treatment , ophthalmologist radiation oncologist perform follow-up examination . The accumulated data analyze use group sequential test . RESULTS : Between February 2007 September 2008 , 104 eye primary pterygium operate accord trial protocol . Additional treatment perform within 24 hour postoperatively . Four patient lose follow-up , result 104 patient could analyze . In 54 eye randomize receive beta-RT , 5 relapse occur compare 8 recurrence 50 eye receive RT , crude control rate 90.7 % vs. 84 % , respectively . At mean follow-up 9 month ( range 4- 18 ) , major treatment complication observe . CONCLUSION : Single-dose beta-RT 1000cGy conjunctival autograft surgery simple , effective , safe treatment reduces risk primary pterygium recurrence .</brief_summary>
	<brief_title>Pterygium Treatment Using Single Beta-therapy Adjuvant Treatment Compared Conjunctival Autograft</brief_title>
	<detailed_description />
	<mesh_term>Pterygium</mesh_term>
	<criteria>Fresh pterygium without previous treatment . Adult patient age high 18 year . Diagnosis glaucoma . Previous treatment pterygium . Patients age less 18 year old .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>beta-irradiation ; conjunctival autograft ; pterygium ; recurrence ; clinical trial</keyword>
</DOC>